Solriamfetol
JZP110-405
Approved small_molecule completed
Quick answer
Solriamfetol for Excessive Daytime Sleepiness is a Approved program (small_molecule) at Axsome Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Axsome Therapeutics
- Indication
- Excessive Daytime Sleepiness
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed